| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| Charles Schwab acct. 3612-9384 - securities | Purchased | 2023-12 | Various | 392,377 | 378,710 | 13,667 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Abbott Laboratories | 147,741 | 132,634 |
| Aberdeen Asia Paci | 95,459 | 74,525 |
| America Movil Sab De CV Adr Sponsored | 50,500 | 59,264 |
| Applied Materials Inc. | 150,705 | 197,725 |
| Bank of New York Mellon Corp | 89,710 | 104,100 |
| Bristol-Myers Squibb Co | 97,220 | 82,096 |
| British American Tobacco | 124,940 | 105,444 |
| Carrier Global Corporation | 181,147 | 218,310 |
| CSX Corp | 143,980 | 156,015 |
| GE Healthcare Technologies | 55,654 | 59,150 |
| Honeywell International Inc | 224,555 | 220,196 |
| Hubbell Inc | 34,162 | 95,390 |
| Lockheed Martin Corp | 42,627 | 54,389 |
| Marsh & Mclennan Companies Inc | 127,305 | 222,627 |
| Merck & Co Inc | 44,512 | 66,284 |
| Microsoft Corp | 127,200 | 360,998 |
| Nextera Energy Inc | 159,962 | 129,255 |
| Parker-Hannifin Corp | 327,374 | 731,592 |
| RTX Corp | 208,273 | 193,522 |
| Southern Co | 32,513 | 38,566 |
| TE Connectivity Ltd | 87,492 | 119,425 |
| Thermo Fisher Scientific Inc | 34,036 | 142,252 |
| Travelers Companies Inc | 62,984 | 100,388 |
| Verizon Communications | 95,769 | 63,638 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| John Hancock Multi-Asset | 89,109 | 98,810 | |
| JP Morgan Income Builder | 77,168 | 72,799 | |
| Miller Convertible Bond Fund | 65,549 | 59,816 | |
| IShares Trust Fltg Rate ETF | 220,567 | 220,197 | |
| Crown Castle REIT | 147,400 | 110,582 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Axley Brynelson Legal and tax prep | 11,019 | 11,019 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Investment fees | 32,565 | 32,565 | ||
| ADR Fees | 503 | 503 |
| Description | Amount |
|---|---|
| Basis adjustments on contributed securities | 88,898 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Income tax estimated payment | 3,000 | |||
| Roche - Foreign Tax | 115 |